Results of paclitaxel-drug-coated balloons (Pantera Lux) for coronary in-stent restenosis: Italian experience from REGistry of Paclitaxel Eluting Balloon in ISR study
Articolo
Data di Pubblicazione:
2021
Citazione:
Results of paclitaxel-drug-coated balloons (Pantera Lux) for coronary in-stent restenosis: Italian experience from REGistry of Paclitaxel Eluting Balloon in ISR study / S. Galli, S. Troiano, M. Tespili, A. Ielasi, G. Niccoli, L. Sommariva, F. Amico, G. Pasquetto, R. Ceravolo, D. Forlani, M. Contarini, M. Del Maestro, P. Montorsi. - In: JOURNAL OF CARDIOVASCULAR MEDICINE. - ISSN 1558-2035. - 22:6(2021 Jun), pp. 469-477. [10.2459/JCM.0000000000001127]
Abstract:
AIMS: Drug-eluting stent (DES) implantation is an effective treatment of in-stent restenosis (ISR). However, literature data indicate that drug-coated balloons (DCBs) may be a valid alternative, particularly for recurrent ISR. We sought to evaluate clinical results on the long-term efficacy of a new DCB for ISR treatment. METHODS: One hundred and ninety-nine patients were treated with paclitaxel drug-coated balloons (Pantera Lux, Biotronik, Switzerland) in the Italian REGistry of Paclitaxel Eluting Balloon in ISR (REGPEB study). Clinical follow-up was scheduled at 1 and 12 months. A subgroup of patients received adjunctive 5-year follow-up. Primary end point was Major Adverse Cardiac Events (MACE) at 1 year. RESULTS: A total of 214 ISR coronary lesions were treated (75.4% DES-ISR). Mean time between stent implantation and DCB treatment is 41 months. DCBs were successfully delivered in 99% of the cases; crossover to a DES occurred in 3% of cases. Procedural success rate was 98.5%. Clinical success rate was 98.5%. First-month follow-up compliance was 98% and freedom from MACE was 96.9%. Twelve-month follow-up compliance was 89.3% with a freedom from MACE rate of 87.3% (CI: 81.3-91.5%). Five-year long-term follow-up showed 65.2% of freedom from MACE. CONCLUSION: Our study confirms that Pantera Lux treatment is effective and well tolerated in ISR, showing good acute and long/very long-term results in the treatment of complex lesions (DES and late ISR).
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
bare metal stent; drug-coated balloon; drug-eluting stent; drug-coated balloon; in-stent restenosis; Aftercare; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Female; Humans; Italy; Male; Outcome and Process Assessment, Health Care; Paclitaxel; Percutaneous Coronary Intervention; Registries; Time; Angioplasty, Balloon, Coronary; Coronary Restenosis; Drug-Eluting Stents; Reoperation
Elenco autori:
S. Galli, S. Troiano, M. Tespili, A. Ielasi, G. Niccoli, L. Sommariva, F. Amico, G. Pasquetto, R. Ceravolo, D. Forlani, M. Contarini, M. Del Maestro, P. Montorsi
Link alla scheda completa: